Terms: = Skin cancer AND Ki-67 AND Staging
20 results:
1. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
2. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
3. Diffuse pattern, orbital invasion, perineural invasion and ki-67 are associated with nodal metastasis in patients with eyelid sebaceous carcinoma.
Gu X; Xie M; Luo Y; Song X; Xu S; Fan X
Br J Ophthalmol; 2023 Jun; 107(6):756-762. PubMed ID: 35063931
[TBL] [Abstract] [Full Text] [Related]
4. Primary Dermal Melanoma: A Case Report.
Weiss A; Christensen RE; Maghari A; Wassef C
Am J Dermatopathol; 2022 Mar; 44(3):212-214. PubMed ID: 34726186
[TBL] [Abstract] [Full Text] [Related]
5. The Utility of 18F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
Feuerman H; Snast I; Amitay-Laish I; Bairey O; Barzilai A; Feinmesser M; Mimouni D; Even-Sapir E; Hodak E
Isr Med Assoc J; 2019 Sep; 21(9):580-584. PubMed ID: 31542900
[TBL] [Abstract] [Full Text] [Related]
6. Association between ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.
Robinson EM; Rosenbaum BE; Zhang Y; Rogers R; Tchack J; Berman RS; Darvishian F; Osman I; Shapiro RL; Shao Y; Polsky D
J Surg Oncol; 2018 Jul; 118(1):150-156. PubMed ID: 29878361
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and Pathological Significance of ER Stress Marker (BiP/GRP78 and PERK) Expression in Malignant Melanoma.
Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
Pathol Oncol Res; 2017 Jan; 23(1):111-116. PubMed ID: 27502501
[TBL] [Abstract] [Full Text] [Related]
8. Expression of SATB1, MTI/II and ki-67 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
[TBL] [Abstract] [Full Text] [Related]
10. [Correlation between tumor cell proliferation and prognosis of primary cutaneous malignant melanoma in 127 patients].
Wang Y; Xue WC; Si L; Cui CL; Lu AP; Cao DF; Guo J; Li ZW
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):178-81. PubMed ID: 23769437
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors in 105 Japanese cases of mycosis fungoides and Sézary syndrome: clusterin expression as a novel prognostic factor.
Tobisawa S; Honma M; Ishida-Yamamoto A; Saijo Y; Iizuka H
J Dermatol Sci; 2013 Sep; 71(3):160-6. PubMed ID: 23702390
[TBL] [Abstract] [Full Text] [Related]
12. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.
Hale CS; Qian M; Ma MW; Scanlon P; Berman RS; Shapiro RL; Pavlick AC; Shao Y; Polsky D; Osman I; Darvishian F
Am J Surg Pathol; 2013 Jun; 37(6):882-9. PubMed ID: 23629443
[TBL] [Abstract] [Full Text] [Related]
13. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson cancer Center.
Li S; Feng X; Li T; Zhang S; Zuo Z; Lin P; Konoplev S; Bueso-Ramos CE; Vega F; Medeiros LJ; Yin CC
Am J Surg Pathol; 2013 Jan; 37(1):14-23. PubMed ID: 23232851
[TBL] [Abstract] [Full Text] [Related]
14. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.
Li L; Zhang Z; Li B; Gao F; Li L; Jonas JB
Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1867-73. PubMed ID: 21739269
[TBL] [Abstract] [Full Text] [Related]
15. ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
[TBL] [Abstract] [Full Text] [Related]
16. Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma.
Belhocine T; Pierard GE; Frühling J; Letesson G; Bolle S; Hustinx R; Dargent JL; Flamen P; Rigo P
Oncol Rep; 2006 Aug; 16(2):347-52. PubMed ID: 16820914
[TBL] [Abstract] [Full Text] [Related]
17. Primary dermal melanoma: a distinct subtype of melanoma.
Swetter SM; Ecker PM; Johnson DL; Harvell JD
Arch Dermatol; 2004 Jan; 140(1):99-103. PubMed ID: 14732666
[TBL] [Abstract] [Full Text] [Related]
18. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract] [Full Text] [Related]
19. Malignant blue naevus with distant subcutaneous metastasis.
Böni R; Panizzon R; Huch Böni RA; Steinert H; Dummer R
Clin Exp Dermatol; 1996 Nov; 21(6):427-30. PubMed ID: 9167338
[TBL] [Abstract] [Full Text] [Related]
20. Cutaneous T cell lymphoma of signet ring cell type: a specific clinico-pathologic entity.
Vaillant L; Monégier du Sorbier C; Arbeille B; de Muret A; Lorette G
Acta Derm Venereol; 1993 Aug; 73(4):255-8. PubMed ID: 7904098
[TBL] [Abstract] [Full Text] [Related]
